RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 113,600 shares, a drop of 18.9% from the March 15th total of 140,000 shares. Based on an average trading volume of 51,600 shares, the days-to-cover ratio is currently 2.2 days. […]
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) – Analysts at Jefferies Financial Group issued their Q1 2023 EPS estimates for RVL Pharmaceuticals in a research report issued on Tuesday, March 21st. Jefferies Financial Group analyst G. Santangelo forecasts that the company will earn ($0.14) per share for the quarter. The consensus estimate for RVL Pharmaceuticals’ […]
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) – Cantor Fitzgerald lifted their FY2023 EPS estimates for shares of RVL Pharmaceuticals in a report issued on Tuesday, March 21st. Cantor Fitzgerald analyst L. Chen now expects that the company will post earnings of ($0.30) per share for the year, up from their prior estimate of ($0.64). […]
RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating)’s stock price was up 5.6% during trading on Wednesday . The company traded as high as $1.35 and last traded at $1.32. Approximately 56,457 shares traded hands during trading, a decline of 65% from the average daily volume of 163,200 shares. The stock had previously closed at $1.25. […]
Brokerages expect RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) to report $13.98 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for RVL Pharmaceuticals’ earnings. The lowest sales estimate is $8.30 million and the highest is $24.54 million. RVL Pharmaceuticals reported sales of $11.51 million in the […]